1349 — Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
HK$3.41bn
Enterprise Value
HK$2.16bn
Revenue
CNY709.40m

Annual balance sheet for Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,397	1,209	1,319	1,196	1,056
Net Total Accounts Receivable
Net Total Receivables	586	677	688	625	472
Total Inventory
Prepaid Expenses
Total Current Assets	2,027	1,928	2,069	1,869	1,607
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	256	322	409	520	509
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,501	2,781	2,976	2,877	2,587
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	428	528	673	505	251
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	490	588	719	519	282
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	2,011	2,193	2,257	2,358	2,305
Total Liabilities & Shareholders' Equity	2,501	2,781	2,976	2,877	2,587
Total Common Shares Outstanding